Year: 2022

GENEXINE_CI

Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the discovery and development of...

generic_link-81

Spackman Media Group Artist Kim Sang-Kyung’s K-Drama, POONG, THE JOSEON PSYCHIATRIST, Breaks Its Own Highest Viewership Records, Ranking First Across All TV Channels In Korea

Headlined by Spackman Media Group artist Kim Sang-kyung, POONG, THE JOSEON PSYCHIATRIST surpassed its own highest viewership records, securing the...